(Q43684840)

25 November 2017

Risk of Misinterpretation of Ebola Virus PCR Results After rVSV ZEBOV-GP Vaccination (English)

1 reference

25 November 2017

0 references

Orthoebolavirus zairense

0 references

1 reference

15

Marjan Van Esbroeck

1 reference

25 November 2017

Steven Callens

10

0 references

Emmanuel Bottieau

13

object named as

Emmanuel Bottieau

1 reference

25 November 2017

1

Lieselotte Cnops

1 reference

25 November 2017

5

Leo Heyndrickx

1 reference

25 November 2017

16

Kevin K Ariën

1 reference

25 November 2017

Michèle Gerard

2

1 reference

25 November 2017

Olivier Vandenberg

3

1 reference

25 November 2017

Sigi Van den Wijngaert

4

1 reference

25 November 2017

Elisabeth Willems

6

1 reference

25 November 2017

Kathy Demeulemeester

7

1 reference

25 November 2017

Hilde De Clerck

8

1 reference

25 November 2017

Anne Dediste

9

1 reference

25 November 2017

Paul De Munter

11

1 reference

25 November 2017

Erika Vlieghe

12

1 reference

25 November 2017

Francoise Wuillaume

14

1 reference

25 November 2017

language of work or name

English

0 references

publication date

18 February 2015

1 reference

Clinical Infectious Diseases

25 November 2017

2

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

25 November 2017

60

1 reference

25 November 2017

11

1 reference

25 November 2017

1725-1726

1 reference

Effective post-exposure treatment of Ebola infection

25 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV131

Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV131

Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV131

Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV131

Emergence of Zaire Ebola Virus Disease in Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV131

Ebola in west Africa: from disease outbreak to humanitarian crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV131

Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV131

Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV131

21 January 2018

Identifiers

DOI

10.1093/CID/CIV131

1 reference

25 November 2017

1 reference